NEW YORK (GenomeWeb) – IMDx said today it has received clearance from the US Food and Drug Administration to market the IMDx HSV-1/2 on the Abbott m2000 instrument.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.